Discussion
Tetanus is quite rare in the United States, which really highlights how effective our vaccination strategies have been. The incidence from 2009 to 2023 was 0.08 cases per million people, which is a bit lower than the 0.10 cases per million reported from 2001 to 2008. When you compare this to the global incidence of about 10.3 cases per million in 2019, it’s more than 100 times lower here. Most cases—about 86%—occur in adults aged 18 and older. Interestingly, the average age of tetanus patients dropped to 40 years during 2009–2023, compared to 49 years in the earlier period. Older adults, especially those over 80, see higher incidence rates, likely because many in this age group didn’t get the primary series of tetanus vaccines that started being recommended in 1947. On the flip side, kids have lower rates, probably due to high vaccination coverage, like over 92% for DTaP vaccines among children born between 2011 and 2021, and 76% for Tdap boosters among teens aged 13–17 during 2009–2024.
The incidence also shows some variation by age and is influenced by gender. For instance, among adults, men tend to have lower seroprotection rates than women, which might be tied to males experiencing more wounds or having different treatment approaches. Still, globally, more men contract tetanus than women.
Tetanus can be very serious. About 95% of patients end up hospitalized, and roughly 1 in 10 may die, with older individuals being particularly at risk; 85% of fatalities are among those aged 65 and up. It’s interesting to note that even though more women seem to die from tetanus, the mortality rate doesn’t differ much between genders when adjusted for age.
Neonatal tetanus cases are rare in the U.S., though they do happen. In the few cases with known birth info, both involved home deliveries, where insufficient maternal vaccination and nonsterile conditions likely played roles. However, in developing countries, neonatal tetanus is much more common due to unsanitary birth practices and low vaccination rates; in 2021, around 8,000 cases were recorded worldwide.
Preventing tetanus and its associated deaths is primarily through routine vaccination and proper wound care. Surprisingly, around half of tetanus patients had no record of receiving the tetanus vaccine, and most of those who had were due for a booster. None of the people who had received at least three doses of the vaccine died, which emphasizes the need for completing vaccination schedules. Many individuals with tetanus had wounds that warranted treatment, yet less than half sought medical care before getting sick. Vaccination was suggested for nearly all cases, but only about a third actually received it. No deaths occurred among those who received the appropriate treatments, underscoring the importance of timely and recommended care.
Even though tetanus is infrequent, healthcare professionals must stay vigilant. Ongoing education about the need for vaccinations in wound management might be beneficial. Previous surveillance data pointed out that more support and awareness are vital for those with wounds to seek prompt care. It’s also essential for healthcare providers to confirm that their patients are up-to-date with vaccinations and to follow proper guidelines for treatment. Lastly, patients recovering from tetanus should receive all necessary vaccinations, as surviving the disease doesn’t make them immune to future infections.
